Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autism-Related Transcription Factors Underlying the Sex-Specific Effects of Prenatal Bisphenol A Exposure on Transcriptome-Interactome Profiles in the Offspring Prefrontal Cortex. | Int J Mol Sci | 2021 | 34947998 | PubTator, text mining | PubMed |
| Healing of Chronic Wounds with Platelet-Derived Growth Factors from Single Donor Platelet-Rich Plasma following One Freeze-Thaw Cycle. A Cross-Sectional Study. | J Clin Med | 2021 | 34945062 | PubTator, text mining | PubMed |
| Hemolytic disease in fetuses and newborns due to antibodies against the M-antigen | Biomedica | 2021 | 34936250 | PubTator, text mining | PubMed |
| Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome. | Nat Commun | 2021 | 34930919 | PubTator, text mining | PubMed |
| Early Hyporegenerative Anemia Complicating Hemolytic Disease of the Newborn Secondary to Rhesus Alloimmunization. | Cureus | 2021 | 34926072 | PubTator, text mining | PubMed |
| RESCOT: Restriction Enzyme Set and Combination Optimization Tools for rNMP Capture Techniques. | Theor Comput Sci | 2021 | 34924677 | PubTator, text mining | PubMed |
| Screening of Asymptomatic Healthcare Workers for SARS-COV-2 for Occult Infections: A Cross-Sectional Study. | Cureus | 2021 | 34909302 | PubTator, text mining | PubMed |
| Case report and strategies to mitigate passive hemolysis with platelet transfusions in children. | Asian J Transfus Sci | 2021 | 34908760 | PubTator, text mining | PubMed |
| Patient blood management in a neurosurgical patient with anti-e antibody. | Asian J Transfus Sci | 2021 | 34908759 | PubTator, text mining | PubMed |
Dynamic changes in genetic diversity, drug resistance mutations, and treatment outcomes of falciparum malaria from the low-transmission to the pre-elimination phase on the islands of São Tomé and Príncipe. | Malar J | 2021 | 34906134 | PubTator, text mining | PubMed |
| Pregnancy Outcome of Rh D Alloimmunized Pregnancies: A Tertiary Care Institute Experience of a Developing Country. | J Obstet Gynaecol India | 2021 | 34898895 | PubTator, text mining | PubMed |
| [Transfusion Strategy for Rare Anti-LW Antibody Autoimmune Hemolytic Anemia Patients with Neonatal Hemolytic Disease]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 | 34893137 | PubTator, text mining | PubMed |
| Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia. | Hemasphere | 2021 | 34881357 | PubTator, text mining | PubMed |
| Is the whole greater than the sum of its parts? The implementation and outcomes of a whole blood program in Ecuador. | Trauma Surg Acute Care Open | 2021 | 34869909 | PubTator, text mining | PubMed |
| The Significance of RHD Genotyping and Characteristic Analysis in Chinese RhD Variant Individuals. | Front Immunol | 2021 | 34867989 | PubTator, text mining | PubMed |
| Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report. | J Med Case Rep | 2021 | 34838142 | PubTator, text mining | PubMed |
| Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma. | Cancer Cell Int | 2021 | 34838000 | PubTator, text mining | PubMed |
| BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma. | Nat Commun | 2021 | 34836971 | PubTator, text mining | PubMed |
| Household Transmission of SARS-CoV-2: A Prospective Longitudinal Study Showing Higher Viral Load and Increased Transmissibility of the Alpha Variant Compared to Previous Strains. | Microorganisms | 2021 | 34835495 | PubTator, text mining | PubMed |
| Frequency of allogenic blood transfusion in patients with gastrointestinal cancer: a cross-sectional study in Peru. | Ecancermedicalscience | 2021 | 34824612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=53